Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


April 26, 2015 1:27 PM ET

Capital Markets

Company Overview of Aisling Capital LLC

Executive Profile

Joshua H. Bilenker M.D.

Founder, Chief Executive Officer, President and Director, Loxo Oncology, Inc.
AgeTotal Calculated CompensationThis person is connected to 7 Board Members in 7 different organizations across 8 different industries.

See Board Relationships
42$5,723,108
As of Fiscal Year 2014

Background

Dr. Joshua H. Bilenker, also known as Josh, MD, is an Operating Partner at Aisling Capital LLC. He previously served as a Principal at the firm. Dr. Bilenker has been the Chief Executive Officer and President of Loxo Oncology, Inc., which he founded May 2013. He served as the Chief Financial Officer and Principal Accounting Officer of Loxo Oncology, Inc. Previously, he served as a Medical Officer in the Office of Oncology Drug Products at the United States Food and Drug ...

Corporate Headquarters

888 Seventh Avenue
New York, New York 10106

United States

Phone: 212-651-6380
Fax: 212-651-6379

Board Members Memberships

Director
Director
Director
2008-Present
Director
2011-Present
Director and Chairman of Nominating & Corporate Governance Committee
2011-2015
Former Director and Member of Audit Committee
2013-Present
Founder, Chief Executive Officer, President and Director

Education

MD
Johns Hopkins School of Medicine
BA
Princeton University

Other Affiliations

Annual Compensation

Salary$350,000
Total Annual Compensation$350,000

Stocks Options

Exercisable Options$333,662
Unexercisable Options$413,782
Total Number of Options$747,444

Total Compensation

Total Annual Cash Compensation$350,000
Total Short Term Compensation$350,000
Total Calculated Compensation$5,723,108
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Aisling Capital LLC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.